サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1411334

美容注射市場：タイプ、用途、エンドユーザー別-2024-2030年の世界予測

Aesthetic Injectables Market by Type (Anti-aging Injections, Dermal Fillers), Application (Acne Scar Treatment, Face Lift, Facial Line Correction), End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 186 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
美容注射市場：タイプ、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月16日
発行: 360iResearch
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

美容注射市場規模は2023年に192億1,000万米ドルと推計され、2024年には220億米ドルに達し、CAGR 10.13%で2030年には377億7,000万米ドルに達すると予測されます。

美容注射の世界市場

主な市場の統計
基準年[2023］ 192億1,000万米ドル
予測年[2024］ 220億米ドル
予測年 [2030] 377億7,000万米ドル
CAGR（%） 10.13%
美容注射 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは美容注射市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、美容注射市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-美容注射市場の市場規模および予測は？

2-美容注射市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-美容注射市場における技術動向と規制の枠組みは？

4-美容注射市場における主要ベンダーの市場シェアは？

5-美容注射市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • リップケアおよびスキンケアトリートメントの需要が急増
      • スパやビューティーサロンの数が増加
      • エステティック業界におけるソーシャルメディアの影響の拡大
    • 抑制要因
      • 美容注射剤のコストが高い
    • 機会
      • エステティック業界における技術の進歩
      • 美学バーチャルおよび遠隔医療の導入の拡大
    • 課題
      • 美容注射剤に伴う健康リスク
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 美容注射市場：タイプ別

  • アンチエイジング注射
    • ボツリヌス毒素A
    • ポリ-L-乳酸（PLLA）微粒子
  • 皮膚充填剤
    • コラーゲンフィラー
    • ヒアルロン酸
    • 合成充填剤

第7章 美容注射市場：用途別

  • ニキビ跡の治療
  • フェイスリフト
  • フェイスライン補正
  • 口唇拡大術
  • 脂肪萎縮症の治療

第8章 美容注射市場：エンドユーザー別

  • 美容クリニック
  • 皮膚科クリニック
  • 皮膚科学調査
  • メディカルスパ

第9章 南北アメリカの美容注射市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の美容注射市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの美容注射市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Adoderm GmbH
    • Allergan, Inc. by AbbVie Inc.
    • Anika Therapeutics, Inc.
    • Bio Plus Co., Ltd.
    • Bioxis Pharmaceuticals
    • Bloomage Biotechnology Corp., Ltd.
    • Bohus Biotech AB
    • Croma-Pharma GmbH
    • Cutera, Inc.
    • Cynosure, LLC
    • Dr. Korman Laboratories Ltd.
    • Galderma SA
    • Hugel America, Inc.
    • Ipsen Pharma
    • Laboratoires Vivacy, S.A.S.
    • MedyTox Inc.
    • Merz Pharma GmbH & Co.KGaA
    • Prollenium Medical Technologies Inc.
    • Revance Therapeutics, Inc.
    • SciVision Biotech Inc.
    • Sinclair Pharma Ltd
    • Suneva Medical, Inc.
    • Teoxane SA
    • USWM, LLC
    • Zimmer Biomet Holdings, Inc.
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. AESTHETIC INJECTABLES MARKET RESEARCH PROCESS
  • FIGURE 2. AESTHETIC INJECTABLES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. AESTHETIC INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. AESTHETIC INJECTABLES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. AESTHETIC INJECTABLES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AESTHETIC INJECTABLES MARKET DYNAMICS
  • FIGURE 7. AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. AESTHETIC INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. AESTHETIC INJECTABLES MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. AESTHETIC INJECTABLES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. AESTHETIC INJECTABLES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AESTHETIC INJECTABLES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 8. AESTHETIC INJECTABLES MARKET SIZE, BY BOTULINUM TOXIN A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. AESTHETIC INJECTABLES MARKET SIZE, BY POLY-L-LACTIC ACID (PLLA) MICRO PARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 12. AESTHETIC INJECTABLES MARKET SIZE, BY COLLAGEN FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AESTHETIC INJECTABLES MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AESTHETIC INJECTABLES MARKET SIZE, BY SYNTHETIC FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AESTHETIC INJECTABLES MARKET SIZE, BY ACNE SCAR TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AESTHETIC INJECTABLES MARKET SIZE, BY FACE LIFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AESTHETIC INJECTABLES MARKET SIZE, BY FACIAL LINE CORRECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AESTHETIC INJECTABLES MARKET SIZE, BY LIP AUGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AESTHETIC INJECTABLES MARKET SIZE, BY LIPOATROPHY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AESTHETIC INJECTABLES MARKET SIZE, BY BEAUTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AESTHETIC INJECTABLES MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AESTHETIC INJECTABLES MARKET SIZE, BY DERMATOLOGY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AESTHETIC INJECTABLES MARKET SIZE, BY MEDICAL SPA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES AESTHETIC INJECTABLES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY ANTI-AGING INJECTIONS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY DERMAL FILLERS, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM AESTHETIC INJECTABLES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. AESTHETIC INJECTABLES MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 236. AESTHETIC INJECTABLES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. AESTHETIC INJECTABLES MARKET LICENSE & PRICING
目次
Product Code: MRR-6702BB65140B

[186 Pages Report] The Aesthetic Injectables Market size was estimated at USD 19.21 billion in 2023 and expected to reach USD 22.00 billion in 2024, at a CAGR 10.13% to reach USD 37.77 billion by 2030.

Global Aesthetic Injectables Market

KEY MARKET STATISTICS
Base Year [2023] USD 19.21 billion
Estimated Year [2024] USD 22.00 billion
Forecast Year [2030] USD 37.77 billion
CAGR (%) 10.13%
Aesthetic Injectables Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Aesthetic Injectables Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Aesthetic Injectables Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Aesthetic Injectables Market, highlighting leading vendors and their innovative profiles. These include Adoderm GmbH, Allergan, Inc. by AbbVie Inc., Anika Therapeutics, Inc., Bio Plus Co., Ltd., Bioxis Pharmaceuticals, Bloomage Biotechnology Corp., Ltd., Bohus Biotech AB, Croma-Pharma GmbH, Cutera, Inc., Cynosure, LLC, Dr. Korman Laboratories Ltd., Galderma SA, Hugel America, Inc., Ipsen Pharma, Laboratoires Vivacy, S.A.S., MedyTox Inc., Merz Pharma GmbH & Co.KGaA, Prollenium Medical Technologies Inc., Revance Therapeutics, Inc., SciVision Biotech Inc., Sinclair Pharma Ltd, Suneva Medical, Inc., Teoxane SA, USWM, LLC, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Aesthetic Injectables Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Anti-aging Injections
      • Botulinum Toxin A
      • Poly-L-Lactic Acid (PLLA) Micro Particles
    • Dermal Fillers
      • Collagen Fillers
      • Hyaluronic Acid
      • Synthetic Fillers
  • Application
    • Acne Scar Treatment
    • Face Lift
    • Facial Line Correction
    • Lip Augmentation
    • Lipoatrophy Treatment
  • End User
    • Beauty Clinics
    • Dermatology Clinics
    • Dermatology Research Institutes
    • Medical Spa
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Aesthetic Injectables Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Aesthetic Injectables Market?

3. What are the technology trends and regulatory frameworks in the Aesthetic Injectables Market?

4. What is the market share of the leading vendors in the Aesthetic Injectables Market?

5. Which modes and strategic moves are suitable for entering the Aesthetic Injectables Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Aesthetic Injectables Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surging demand in lip care and skin care treatments
      • 5.1.1.2. Increasing number of spa and beauty salons
      • 5.1.1.3. Growing impact of social media in aesthetic industry
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of aesthetic injectibles
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in aesthetics industry
      • 5.1.3.2. Growing adoption of aesthetics virtual and telemedicine
    • 5.1.4. Challenges
      • 5.1.4.1. Health risks associated with the aesthetics injectables
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Aesthetic Injectables Market, by Type

  • 6.1. Introduction
  • 6.2. Anti-aging Injections
    • 6.3.1. Botulinum Toxin A
    • 6.3.2. Poly-L-Lactic Acid (PLLA) Micro Particles
  • 6.3. Dermal Fillers
    • 6.4.1. Collagen Fillers
    • 6.4.2. Hyaluronic Acid
    • 6.4.3. Synthetic Fillers

7. Aesthetic Injectables Market, by Application

  • 7.1. Introduction
  • 7.2. Acne Scar Treatment
  • 7.3. Face Lift
  • 7.4. Facial Line Correction
  • 7.5. Lip Augmentation
  • 7.6. Lipoatrophy Treatment

8. Aesthetic Injectables Market, by End User

  • 8.1. Introduction
  • 8.2. Beauty Clinics
  • 8.3. Dermatology Clinics
  • 8.4. Dermatology Research Institutes
  • 8.5. Medical Spa

9. Americas Aesthetic Injectables Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Aesthetic Injectables Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Aesthetic Injectables Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Adoderm GmbH
    • 13.1.2. Allergan, Inc. by AbbVie Inc.
    • 13.1.3. Anika Therapeutics, Inc.
    • 13.1.4. Bio Plus Co., Ltd.
    • 13.1.5. Bioxis Pharmaceuticals
    • 13.1.6. Bloomage Biotechnology Corp., Ltd.
    • 13.1.7. Bohus Biotech AB
    • 13.1.8. Croma-Pharma GmbH
    • 13.1.9. Cutera, Inc.
    • 13.1.10. Cynosure, LLC
    • 13.1.11. Dr. Korman Laboratories Ltd.
    • 13.1.12. Galderma SA
    • 13.1.13. Hugel America, Inc.
    • 13.1.14. Ipsen Pharma
    • 13.1.15. Laboratoires Vivacy, S.A.S.
    • 13.1.16. MedyTox Inc.
    • 13.1.17. Merz Pharma GmbH & Co.KGaA
    • 13.1.18. Prollenium Medical Technologies Inc.
    • 13.1.19. Revance Therapeutics, Inc.
    • 13.1.20. SciVision Biotech Inc.
    • 13.1.21. Sinclair Pharma Ltd
    • 13.1.22. Suneva Medical, Inc.
    • 13.1.23. Teoxane SA
    • 13.1.24. USWM, LLC
    • 13.1.25. Zimmer Biomet Holdings, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing